由『現代化中醫藥國際協會(MCMIA)』主辦之「國際現代化中醫藥及健康產品會議(ICMCM)」於2022年8月11-12日假香港會議展覽中心N101B舉行。MCMIA感謝香港貿易發展局、所有籌委會成員及協辦單位的鼎力支助,使ICMCM 得以順利舉行。
今年ICMCM 的主題是「中藥創新藥物研發及臨床研究」,會議16位講者分別來自美國、奧地利、德國、澳洲、日本、中國內地及香港。會議將包括以下五個環節。(詳細議程,請參閱附件。)
· 主題演講
· 從中醫臨床到中藥新藥
· 最新中藥科研成果
· 產品商業化及成功個案分享
· 第十八屆國際研究生中醫藥研討會
重溫會議內容:
11/ 8 / 2022 (Thursday星期四)
ICMCM Opening Ceremony 開幕禮
點擊觀看 https://drive.google.com/file/d/16yTJhLZh2ppQwB_07nXXNHXYnOO4nvLC/view?usp=sharing
Session 1: Keynote Speech
第一節: 主題演講
點擊觀看 https://drive.google.com/file/d/1wGj3v0Gm_6scQoetRdBchdibfeQdMQoc/view?usp=sharing
(中文)
https://drive.google.com/file/d/100aPoUHFBqqF9YgQ2KhWwyCJCmxfP07A/view?usp=sharing
(英文)
Ø 未來醫學 融貫中西:WE Medicine
Prof Yung-Chi Cheng, Henry Bronson Professor of Pharmacology and Medicine, Yale University
美國耶魯大學醫學院藥理學系講座教授鄭永齊教授
Ø 從中醫藥尋找抗新冠藥物創新轉化的源泉
Professor Zifeng Yang, Associate Dean, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health
廣州醫科大學附屬第一醫院廣州呼吸健康研究院副院長 楊子峰教授
Ø The basic and clinical research of anti-depressive effect of Lycium Bararum Glycopeptides
枸杞糖肽抗抑鬱的基礎研究和臨床實驗
Professor Kwok-Fai So, Jinan University, Guangdong-HongKong-Macau Institute of CNS Regeneration
Session 2: From CM clinical studies to new CM products
第二節: 從中醫臨床到中藥新藥
點擊觀看 https://drive.google.com/file/d/1qAznBqyWK_RlOtAGHr94DL_pE-V40U83/view?usp=sharing
(中文)
https://drive.google.com/file/d/1xXtFvq4Qeu39ygPv2oAp9h-QdZD-jzi-/view?usp=sharing
(英文)
Ø COVID-19 and Chinese Herbal Medicine – from clinical research to practical use
Professor Ka Kit Hui, UCLA Department of Medicine
Ø The impact of individual gut microbiota on activity of Chinese herbal medicine
Professor Rudolf Bauer, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria
Ø Phytomedicine application in clinical practice
Professor Thomas Efferth, Johannes Gutenberg University, Institute of Pharmaceutical and Biomedical Sciences, Mainz, Germany
Ø Chemical characterization of Prunella vulgaris Glycoconjugates and its anti-HSV Activities
夏枯草多糖複合物的化學表徵及抗皰疹病毒的活性研究
Dr Li Yang, Shanghai University of Traditional Chinese Medicine
上海中醫藥大學中藥學院 李洋博士
Session 3: R&D on Chinese Medicines
第三節: 最新中藥科研成果
點擊觀看 https://drive.google.com/file/d/1BuGpqxUiDBYfyKy2mQ4v-G927YuhyEhO/view?usp=sharing
(中文)
https://drive.google.com/file/d/1dqiiE8BCfcdVjUZFTSrXcidSdzH1PZW-/view?usp=sharing
(英文)
Ø Basic and clinical research on the development of new anti-cancer drug elemene liposome based on the theory of “molecular compatibility” of integrated traditional Chinese and western medicine
中西醫結合“分子配伍”理論研發抗癌新藥欖香烯脂質體的基礎與臨床研究
杭州師範大學醫學院整合藥學院院長 謝恬教授
Ø Effectiveness and mechanism of Liu-wei-di-huang-wan (Rehammnia-6)-based treatment for diabetic kidney disease
Dr Chan Kam Wa, Department of Medicine, School of Clinical Medicine, the University of Hong Kong
香港大學臨床醫學院 陳錦華博士
Ø A RCT of application of Zishen Yutai Pill in IVF-ET
滋腎育胎丸在IVF-ET中應用的隨機對照臨床研究
Professor Yang Dongzi, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
中山大學孫逸仙紀念醫院 楊冬梓教授
Ø Development of a novel standardised herbal intervention for the treatment of vascular dementia
Professor Dennis Chang, Director, NICM Health Research Institute, Western Sydney University, NSW, Australia
12/ 8 / 2022 (Friday星期五)
Session 4: Product Commercialization & Successful Cases Sharing
第四節: 產品商業化及成功個案分享
點擊觀看 https://drive.google.com/file/d/1SFEZF5NyTrA8SGIoS2g3sqRvwiOUrntD/view?usp=sharing
(中文)
https://drive.google.com/file/d/1y37Z7kraMn3oONU73xfJ3I0Rc8ggfyG8/view?usp=sharing
(英文)
Ø GI research with Chinese herbal medicine, from clinical research to new drug discovery
Professor Bian Zhao Xiang, Associate Vice-President (Chinese Medicine Development), Hong Kong Baptist University
香港浸會大學協理副校長 (中醫藥發展) 卞兆祥教授
Ø Randomized, double-blind, and placebo-controlled clinical trials on rare Chinese medicinal materials: Red Ginseng and Ejiao
Professor Li Zhang, Shanghai University of Traditional Chinese Medicine
上海中醫藥大學 張莉教授
Ø Adjuvant therapy of Coriolus versicolor extracts for cancer
雲芝提取物的癌症輔助治療
Dr Xiaoyu JI, R&D project coordinator, Purapharm Corporation Ltd
培力(香港)健康產品有限公司研發項目統籌主任 季曉宇博士
Ø Dendrobium Officinale and the Promotion and Development of Traditional Chinese Medicine Culture
鐵皮石斛與弘揚發展中醫藥文化
Mr Chen Lizuan, Director, Zhejiang Tianhuang Medicinal Plant Pharmaceutical Co.,Ltd
浙江天皇藥業有限公司董事長 陳立鑽先生
Ø Successful commercialization of an anti-aging ingredient based on advanced research: Latest advancement of SIRTMAX® (Kaempferia parviflora extract) in SIRT1 activation and clinical study
以高端科技為基礎抗衰老原料的成功開發以及產業化: SIRTMAX® (Kaempferia parviflora extract) 的SIRT1 活性化研究和臨床研究的最新進展
Dr Jin Tatsuzaki, President & CEO, TOKIWA Phytocamical Co., LTD
株式會社常磐植物化學研究所社長 & CEO 立崎 仁博士
Ø Memorial lecture in memory of Dr. Albert Wong, Founding President of MCMIA
現代化中醫藥國際協會創會會長黃伯偉博士紀念演講
Professor Xu Hong Xi, Distinguished Professor, Shanghai University of Traditional Chinese Medicine
上海中醫藥大學中藥學院首席教授 徐宏喜教授
Session 5: The 18th International Postgraduate Symposium on Chinese Medicine
第五節: 第18屆國際研究生中醫藥研討會
點擊觀看 https://drive.google.com/file/d/1Ada3vm_DizDWT7io22jFoQRaJkK7K8fa/view?usp=sharing
(中文)
https://drive.google.com/file/d/13t94iDrNW8YFRo2aYB5-eZaujcO5DNoL/view?usp=sharing
(英文)
Ø The 18th International Postgraduate Symposium on Chinese Medicine
第18屆國際研究生中醫藥研討會
Closing Remarks 閉幕總結
會員申請表格
有意參加本會者,請向協會辦事處([852] 2492-2713)索取表格或下載會員申請表格 Adobe Acrobat PDF檔 或 Microsoft Word 檔)。 並將填妥之表格連同劃線支票或匯票寄回辦事處。支票/匯票抬頭請寫: Modernized Chinese Medicine International Association Limited。